10 Results for "

nodule formation

" in MedChemExpress (MCE) Product Catalog:
Products (10)

10 Results for "nodule formation" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-110280
CAS No.: 1776116-74-5
Purity:  99.20%
Target:  

HDAC Apoptosis

Research Areas:  

Cancer

MC1742 is a potent HDAC inhibitor, with IC50s of 0.1 μM, 0.11 μM, 0.02 μM, 0.007 μM, 0.61 μM, 0.04 μM and 0.1 μM for HDAC1, HDAC2, HDAC3, HDAC6, HDAC8, HDAC10 and HDAC11, respectively. MC1742 can increase acetyl-H3 and acetyl-tubulin levels and inhibits cancer stem cells growth. MC1742 can induce growth arrest, apoptosis, and differentiation in sarcoma CSC .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-169703
CAS No.: 1251839-15-2
Research Areas:  

Inflammation/Immunology

SPA0355 is a thiourea derivative that has antioxidant and anti-inflammatory properties. SPA0355 inhibits the RANKL (receptor activator of nuclear factor κB ligand) induced osteoclast formation in primary bone marrow-derived macrophages. SPA0355 also suppresses the activation of the MAPKs, Akt, and NF-κB pathways. Additionally, SPA0355 promotes osteoblast differentiation, increases alkaline phosphatase activity, and enhances mineral nodule formation. SPA0355 can protect ovariectomized mice from bone loss by stimulating osteoblast differentiation and inhibiting osteoclast resorption, making it useful for studying postmenopausal osteoporosis .
loading...
    loading...
Cat. No.: HY-D0833
CAS No.: 7758-87-4
Research Areas:  

Metabolic Disease

Tricalcium phosphate is a calcium-phosphorus compound mainly composed of calcium ions and phosphate (PO4 3-). Tricalcium phosphate promotes osteogenic differentiation, inhibits adipogenic and chondrogenic differentiation, and serves as a scaffold for spinal fusion implants. Tricalcium phosphate supports reparative dentin formation, mineralized nodule formation, and calcium ion release. Tricalcium phosphate is commonly used in fields such as biomaterials, bone repair, food additives, and pharmaceutical preparations .
loading...
    loading...
Cat. No.: HY-145121
CAS No.: 2871872-79-4
Purity:  99.93%
DS96432529 is an orally active CDK8 inhibitor with an IC50 of 33 nM. DS96432529 enhances ALPase activity, with an EC200 of 63 nM. DS96432529 inhibits TNF-α-induced activation of the RLR signaling pathway, activates mitophagy, accelerates mineralized nodule formation, and suppresses the proliferation of periodontal ligament stem cells. DS96432529 promotes bone formation, alleviates ligation-induced alveolar bone loss, and increases bone mineral density in ovariectomized animal models. DS96432529 can be used in studies related to periodontitis and osteoporosis .
loading...
    loading...
Cat. No.: HY-138822
CAS No.: 102783-53-9
Purity:  ≥95.0%
Synonyms: 2,3-DPG pentasodium salt
Target:  

Endogenous Metabolite

Research Areas:  

Cardiovascular Disease

2,3-Diphospho-D-glyceric acid (2,3-DPG) pentasodium salt is a hemoglobin binder and vascular calcification inhibitor that reduces the oxygen affinity of hemoglobin. 2,3-Diphospho-D-glyceric acid pentasodium salt also specifically delays the transformation of colloidal calciprotein particles into crystalline forms, thereby effectively inhibiting vascular smooth muscle cell calcification without affecting the normal formation of osteoid nodules in osteoblast-like cells. 2,3-Diphospho-D-glyceric acid pentasodium salt shows no cytotoxicity to tested cell lines and only weakly interferes with β-hematin formation mediated by glyceryl monopalmitate. 2,3-Diphospho-D-glyceric acid pentasodium salt can be used to study the pathological mechanisms of vascular calcification and malaria-related conditions .
loading...
    loading...
Cat. No.: HY-B1341
CAS No.: 68-23-5
Synonyms: Enidrel; SC-4642; NSC 15432
Norethynodrel (Enidrel; SC-4642) is an orally active progestogen analog that reduces estrogen-like effects and enhances progestogen-like responses in endometrial stromal cells. Norethynodrel also promotes cell maturation and predecidual cell formation by inducing organelle hyperplasia and glycogen accumulation. Norethynodrel competitively inhibits drug-metabolizing enzymes in rat liver microsomes, thereby prolonging Pentobarbital sleep time, while exhibiting multiple effects including reduced body weight gain, attenuated heart rate elevation and ovulation inhibition. In mouse models, Norethynodrel significantly increases the incidence of mammary adenocarcinoma, cervical cancer and pituitary tumors. Norethynodrel can be used for mechanism research on related diseases such as mammary adenocarcinoma, cervical cancer, ovarian tubular adenoma and pituitary adenoma .
loading...
    loading...
Cat. No.: HY-189053
CAS No.: 303970-80-1
Research Areas:  

Others

AG690 is a phenoloxidase inhibitor and immunosuppressant. AG690 reduces the expression and activity of phenoloxidase, inhibits cellular immune responses including hemocyte phagocytosis, nodule formation and encapsulation, and suppresses the activities of superoxide dismutase (SOD), peroxidase and lysozyme, thereby enhancing the insecticidal toxicity of λ-cyhalothrin against Spodoptera litura larvae. AG690 can be used as an insecticide synergist in related research .
loading...
    loading...
Cat. No.: HY-P11854
Target:  

Apoptosis

Research Areas:  

Cancer

SWQIGGN is an oligopeptide targeting ovarian cancer cells. SWQIGGN inhibits the viability, proliferation, migration, invasion and cell adhesion of ovarian cancer cells and promotes apoptosis. SWQIGGN reduces ascites volume and tumor nodule formation in mouse models. SWQIGGN can be used in studies related to ovarian cancer .
loading...
    loading...
Cat. No.: HY-110280R
CAS No.: 1776116-74-5
Research Areas:  

Cancer

MC1742 (Standard) is the analytical standard of MC1742 (HY-110280). This product is intended for research and analytical applications. MC1742 is a potent HDAC inhibitor, with IC50s of 0.1 μM, 0.11 μM, 0.02 μM, 0.007 μM, 0.61 μM, 0.04 μM and 0.1 μM for HDAC1, HDAC2, HDAC3, HDAC6, HDAC8, HDAC10 and HDAC11, respectively. MC1742 can increase acetyl-H3 and acetyl-tubulin levels and inhibits cancer stem cells growth. MC1742 can induce growth arrest, apoptosis, and differentiation in sarcoma CSC .
loading...
    loading...
Cat. No.: HY-145121R
CAS No.: 2871872-79-4
DS96432529 (Standard) is the analytical standard of DS96432529 (HY-145121). This product is intended for research and analytical applications. DS96432529 is an orally active CDK8 inhibitor with an IC50 of 33 nM. DS96432529 enhances ALPase activity, with an EC200 of 63 nM. DS96432529 inhibits TNF-α-induced activation of the RLR signaling pathway, activates mitophagy, accelerates mineralized nodule formation, and suppresses the proliferation of periodontal ligament stem cells. DS96432529 promotes bone formation, alleviates ligation-induced alveolar bone loss, and increases bone mineral density in ovariectomized animal models. DS96432529 can be used in studies related to periodontitis and osteoporosis .
loading...
    loading...